Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | MPI | P34949 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2884877 | 0.92 | MPI (0.36) | LMNAALDH1A1HSD17B10MPITDP1 | |
| SCHEMBL215097 | 0.92 | MPI (0.36) | LMNAALDH1A1HSD17B10MPITDP1 | |
| SCHEMBL13430949 | 0.92 | MPI (0.36) | LMNAALDH1A1HSD17B10MPITDP1 | |
| SCHEMBL426315 | 0.92 | MPI (0.36) | LMNAALDH1A1HSD17B10MPITDP1 | |
| Butyric Acid SCHEMBL4604017 | 0.89 | FFAR3 (0.38) | LMNAALDH1A1FFAR3USP2CYP3A4 | |
| SCHEMBL7066959 | 0.86 | MPI (0.37) | LMNAALDH1A1HSD17B10MPITDP1 | |
| SCHEMBL7068623 | 0.86 | MPI (0.37) | LMNAALDH1A1HSD17B10MPITDP1 | |
| SCHEMBL7070578 | 0.86 | MPI (0.37) | LMNAALDH1A1HSD17B10MPITDP1 | |
| Carboxymethoxylamine SCHEMBL6823099 | 0.85 | TSHR (0.40) | — | |
| SCHEMBL2885041 | 0.81 | MPI (0.34) | LMNAALDH1A1MPIMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250163247-A1 | RESIN COMPOSITION, APPLICATION THEREOF, AND MOLDING METHOD THEREFOR | OSAKA GAS CHEMICALS CO., LTD. (JP) | 2025-05-22 | — | — | US | disclosed |
| WO-2025033407-A1 | MATERIAL, ORGANIC-INORGANIC HYBRID MATERIAL, AND METHOD FOR PRODUCING SAME | 積智研究院合同会社 | 2025-02-13 | — | — | WO | disclosed |
| CN-118647665-A | Resin composition, use thereof and molding method | 大阪燃气化学有限公司 | 2024-09-13 | — | — | CN | disclosed |
| WO-2023166943-A1 | RESIN COMPOSITION, APPLICATION THEREOF, AND MOLDING METHOD THEREFOR | 大阪ガスケミカル株式会社 | 2023-09-07 | — | — | WO | disclosed |
| EP-1942869-A2 | CARBOXYALKYL CELLULOSE ESTERS FOR SUSTAINED DELIVERY OF PHARMACEUTICALLY ACTIVE SUBSTANCES | EASTMAN CHEMICAL COMPANY (US) | 2008-07-16 | — | — | EP | disclosed |
| WO-2007056125-A2 | CARBOXYALKYL CELLULOSE ESTERS FOR SUSTAINED DELIVERY OF PHARMACEUTICALLY ACTIVE SUBSTANCES | EASTMAN CHEMICAL COMPANY (US) | 2007-05-18 | — | — | WO | disclosed |
| US-20070104787-A1 | Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances | EASTMAN CHEMICAL COMPANY | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070104787-A1 | Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances | SLC2A1, SLC2A8, SLC2A4 | LMNA 4523/4885ALDH1A1 1230/4885HSD17B10 2153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.